IMA vs PODD · rev $9.2M vs P/E 34, rev $2.07B
ImageneBio, Inc. (IMA) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
IMA currently screens at market cap $64.7M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the IMA and PODD stock pages for the full models.
Not investment advice.